View Older Stories

May 21, 2026 05:51AM Maxim Group Upgrades Gilead Sciences (GILD) to Buy

May 20, 2026 04:19PM Gilead Sciences issues $3 billion in senior notes across four tranches

May 11, 2026 08:42AM RBC Capital on Gilead Sciences (GILD): 'What To Look For In Upcoming UC Readout'

May 8, 2026 06:18AM Gilead Sciences (GILD) PT Lowered to $168 at Morgan Stanley

May 8, 2026 04:42AM Stocks expected to have increasing option volume: GILD OPEN SYNA ARLO HUBS FROG SG WEN FIS MXK MELI MCHP RILY RNG QCOM SERV LOCO YELP REAL IREN GSAT MSI

May 7, 2026 04:07PM Gilead Sciences (GILD) Tops Q1 EPS by 13c, Beats on Revenue; Offers FY26 Guidance

May 7, 2026 10:38AM Gilead Sciences (GILD) call put ratio 1 call to 1.3 puts with a focus on May 8 weekly 135 calls into quarter results

May 6, 2026 11:08AM Gilead Sciences (GILD) call put ratio 1.9 calls to 1 put with a focus on June options into quarter results

Apr 16, 2026 06:33AM RBC Capital Reiterates Sector Perform Rating on Gilead Sciences (GILD), flags Yeztugo risks

Apr 14, 2026 12:03PM PEPFAR and Global Fund expand lenacapavir access to 1 million more people

Apr 13, 2026 05:52AM Bernstein on US Pharma and Biotech: Who might buy whom?

Apr 9, 2026 07:03AM Gilead exercises option for Kymera's cancer drug candidate KT-200

Apr 8, 2026 09:14AM Gilead Sciences (GILD) PT Raised to $155 at Truist Securities

Apr 8, 2026 09:02AM TD Cowen on Gilead Sciences (GILD): 'We Are Excited By Gilead's Recent String Of Deals'

Apr 8, 2026 08:52AM BMO Capital Reiterates Outperform Rating on Gilead Sciences (GILD)

Apr 8, 2026 07:45AM Gilead Sciences (GILD) Reiterated at Overweight by Cantor Fitzgerald on Likely Positive Call

Apr 8, 2026 06:01AM Oppenheimer on Gilead Sciences (GILD): 'Story Near-Term Remains Squarely HIV Focused'

Apr 7, 2026 08:59AM Gilead Sciences (GILD) PT Raised to $123 at RBC Capital

Apr 7, 2026 08:32AM Gilead Sciences to acquire Tubulis for up to $5 billion

Apr 7, 2026 08:01AM Gilead To Buy Tubulis For $3.15B Cash, Up To $1.85B Contingent - Bloomberg

Apr 6, 2026 07:39AM Gilead Sciences (GILD) Reiterated at Overweight by Cantor Fitzgerald on Yeztugo TRx Gains

Mar 31, 2026 09:32AM UBS Reiterates Buy Rating on Gilead Sciences (GILD)

Mar 31, 2026 06:19AM Galapagos enters partnership with Gilead for autoimmune drug development

Mar 27, 2026 11:27AM Deutsche Bank stays Buy rated on Gilead Sciences (GILD) amid weekly scripts

Mar 24, 2026 03:02PM Clear Street Reiterates Buy Rating on Cullinan Oncology Inc. (CGEM)

Mar 24, 2026 08:13AM Bernstein on Gilead Sciences (GILD) Amid Ouro Acquisition

Mar 24, 2026 06:36AM Goldman Sachs: 'we expect GILD to continue to engage in strategic BD'

Mar 24, 2026 05:23AM Truist on Gilead Sciences (GILD): 'old Rush: $2B Deal for Ouro Adds I&I Strength with BCMAxCD3 TCE in Orphan Autoimmune Indications

Mar 23, 2026 06:30PM Gilead to buy Ouro Medicines for up to $2.2 billion

Mar 23, 2026 12:34PM Gilead nears up to $2bn deal for autoimmune biotech Ouro Medicines - FT

Mar 17, 2026 07:36AM Cantor Fitzgerald Reiterates Overweight Rating on Gilead Sciences (GILD)

Mar 10, 2026 05:38AM Jefferies Starts Amgen (AMGN) at Hold

Mar 10, 2026 05:38AM Jefferies Starts Vertex (VRTX) at Buy

Mar 10, 2026 05:38AM Jefferies Starts Gilead Sciences (GILD) at Buy

Mar 6, 2026 08:25AM BofA Securities Reiterates Buy Rating on Gilead Sciences (GILD) as weekly Yeztugo scripts accelerate

Feb 25, 2026 01:50PM Gilead HIV drug combination maintains viral suppression in phase 3 trials

Feb 25, 2026 10:02AM UBS Reiterates Buy Rating on Gilead Sciences (GILD) Following ACLX Acquisition Announcement

Feb 24, 2026 09:38AM Truist Securities Reiterates Buy Rating on Gilead Sciences (GILD)

Feb 24, 2026 08:23AM Bernstein on Gilead Sciences (GILD) Post Arcellx Acquisition: 'We Like This Deal'

Feb 23, 2026 12:32PM Morgan Stanley: 'Big picture this acquisition bolsters GILD's established position in CAR-T in oncology'

Feb 23, 2026 09:31AM Raymond James on Legend Biotech Corp. (LEGN): 'Arcellx Takeout Indicates Legend is Hugely Undervalued'

Feb 23, 2026 08:09AM Truist Securities Downgrades Arcellx Inc. (ACLX) to Hold

Feb 20, 2026 06:02AM Barclays Starts Gilead Sciences (GILD) at Equalweight

Feb 18, 2026 10:27AM Gilead Sciences (GILD) PT Raised to $175 at UBS

Feb 12, 2026 05:40AM Gilead Sciences (GILD) PT Raised to $170 at Wolfe Research

Feb 11, 2026 09:33AM Gilead Sciences (GILD) PT Raised to $152 at Truist Securities

Feb 11, 2026 09:27AM Gilead Sciences (GILD) PT Raised to $160 at Bernstein SocGen Group

Feb 11, 2026 08:36AM Gilead Sciences (GILD) PT Raised to $162 at BofA Securities

Feb 11, 2026 07:09AM Gilead Sciences (GILD) PT Raised to $170 at Needham

Feb 11, 2026 05:08AM Gilead Sciences (GILD) PT Raised to $160 at BMO Capital

View Older Stories